Table 2.
Group | Bout | WBC (103/μL) | Neutrophil Percent | Neutrophil Count (103/μL) | Lymphocyte Percent | Lymphocyte Count (103/μL) | Monocyte Percent | Monocyte Count (103/μL) |
---|---|---|---|---|---|---|---|---|
BCAA-CHO | T1 | 6.51 ± 0.35 | 55.46 ± 2.45 | 3.64 ± 0.28 | 34.06 ± 2.41 | 2.03 ± 0.13 | 7.18 ± 0.32 | 0.49 ± 0.04 |
24 h post bout 1 | 6.19 ± 0.26 | 56.77 ± 1.96 | 3.52 ± 0.21 | 31.79 ± 1.38 | 2.04 ± 0.15 | 7.48 ± 0.33 | 0.47 ± 0.03 | |
24 h post bout 2 | 6.43 ± 0.26 | 58.35 ± 2.51 | 3.97 ± 0.31 | 32.11 ± 2.33 | 1.89 ± 0.19 | 6.86 ± 0.31 | 0.44 ± 0.03 | |
48 h post bout 3 (T2) | 6.56 ± 0.37 | 57.26 ± 1.81 | 3.69 ± 0.29 | 31.21 ± 1.90 | 1.98 ± 0.10 | 7.25 ± 0.24 | 0.49 ± 0.03 | |
CHO | T1 | 6.44 ± 0.35 | 55.43 ± 2.59 | 3.53 ± 0.29 | 32.61 ± 2.03 | 2.11 ± 0.12 | 8.21 ± 0.45 | 0.57 ± 0.03 |
24 h post bout 1 | 5.85 ± 0.32 | 53.54 ± 2.24 | 3.20 ± 0.28 | 32.43 ± 2.35 | 1.91 ± 0.12 | 8.75 ± 0.52 ‡ | 0.50 ± 0.03 | |
24 h post bout 2 | 5.81 ± 0.33 | 53.18 ± 2.92 | 3.05 ± 0.28 | 33.76 ± 2.79 | 1.90 ± 0.13 | 9.16 ± 0.40 ‡ | 0.55 ± 0.03 | |
48 h post bout 3 (T2) | 6.21 ± 0.32 | 53.15 ± 2.06 | 3.34 ± 0.24 | 30.37 ± 2.14 | 1.90 ± 0.12 | 9.15 ± 0.38 ‡† | 0.59 ± 0.03 |
Abbreviations BCAA-CHO branched-chain amino acid and carbohydrate-supplemented group, CHO carbohydrate only-supplemented group
Analysis of monocyte percentages revealed a group*time interaction (p = 0.01) whereby BCAA-CHO supplementation attenuated increases in monocyte percentages 24 h following bout 1 (p = 0.049), 24 h following bout 2 (p < 0.001), and 48 h following bout 3 (or at T2; p < 0.001) compared to CHO supplementation (denoted by bold lettering and superscript ‡ symbol). Moreover, T2 monocyte percentages increased within the CHO group at T2 compared to T1 (denoted by superscript † symbol, p = 0.012)